Back

Serum proteomic profiling reveals potential inflammatory biomarkers in long-COVID patients: a comparative analysis with healthy controls

2 September 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular consequences of infection, inflammation, and autoimmune disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Maria Grazia De Angelis

Spedali Civili, University Of Brescia, Brescia (Italy)

6 More presentations in this session

Presentation thumbnail
Prolonged ventricular repolarization acts as an independent predictor of sepsis prognosis: a cohort study and insights into intracardiac electrophysiology
Doctor W. Liu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic evaluation with cardiac magnetic resonance in patients with systemic sclerosis
Mr J. Fernandez (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Association between dyspnea, chest pain, nt-probnp and cardiac impairment in people with cystic fibrosis
Doctor M. Dons (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
High-sensitive cardiac troponin T in patients with idiopathic inflammatory myopathies
Doctor P. Barros E Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
A systematic assessment of myocardial involvement and cardiovascular events up to six months in patients hospitalised with COVID-19
Mr N. Wilmes (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular consequences of infection, inflammation, and autoimmune disease

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Session
COVID-19 and the heart
thumbnail
Congress Presentation
Neuroendocrine and multisystem imaging perspectives of post-COVID-19 recovery
thumbnail
Congress Presentation
Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources